CN1357360A - Hypoglycemic biopreparation - Google Patents

Hypoglycemic biopreparation Download PDF

Info

Publication number
CN1357360A
CN1357360A CN01130450A CN01130450A CN1357360A CN 1357360 A CN1357360 A CN 1357360A CN 01130450 A CN01130450 A CN 01130450A CN 01130450 A CN01130450 A CN 01130450A CN 1357360 A CN1357360 A CN 1357360A
Authority
CN
China
Prior art keywords
fermentation
biopreparation
hypoglycemic
preparation
gram
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN01130450A
Other languages
Chinese (zh)
Other versions
CN1239166C (en
Inventor
丁志
郭基成
郭飞融
丁奕翔
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CNB011304502A priority Critical patent/CN1239166C/en
Publication of CN1357360A publication Critical patent/CN1357360A/en
Application granted granted Critical
Publication of CN1239166C publication Critical patent/CN1239166C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Images

Landscapes

  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

The hypoglycemic biopreparation consists of several microbe coloies and their metabolic product and is prepared through conventional activation, enlarged culture, fermentation, filtering, dregs elimination, disinfection, freeze drying and other steps. The biopreparation can regulate body's metabolic function comprehensively, repair pathological insulin tissue and restore its physiological function, promote insulin secretion, increase insulin amount, increase the sensitvity of beta cell to insulin, inhibit and eliminate pathogenic factors and thus lower blood sugar and urine glucose. Animal experiment proves its no toxic side effect. clinical application shows that the biopreparation has obvious curative effect of lowering blood sugar and urine glucose as well as certain curative effect of lowering blood lipoid and blood viscosity.

Description

Hypoglycemic biopreparation
Technical field
The present invention relates to a kind of hypoglycemic biopreparation that utilizes the micropopulation development, said preparation is applicable to diabetics
Background technology
Diabetes are a kind of general chronic progressive diseases, are a kind of very complicated endocrine metabolism diseases.Its basic pathology is absoluteness or relative property hypoinsulinism, and the β cell reduces the sensitivity of insulin and endocrine disturbance's disease of causing, and then causes sugar, protein, fat and water, metabolic disturbance of electrolyte in the human body.Along with the easy concurrent pink man change of prolongation of time, serious threat health and life security.It is reported that up to the present the whole world has 300,000,000 people to suffer from diabetes approximately, wherein domestic just have more than 6,000 ten thousand people.
Current, the medicine of treatment diabetes is many, but great majority blood sugar lowering Western medicine and to keep on a diet be main adopts insulin injection in case of necessity.Western medicine biguanides, flavonoid medicine may command blood glucose, glucose in urine raises so that reach normal.Release Chinese medicine preparation treatment diabetes recently again, have " Chinese medicine live pancreas element ", " the blood sugar lowering pancreas is multiple red ", " JIANGTANGNING JIAONANG ", " sugared recovery capsule " etc. to be used for blood sugar lowering, glucose in urine etc.
In recent years, people begin to note utilizing biotechnology and microbial resources to extract its metabolite and make medicine in order to the treatment diabetes.For example: Chinese patent 99105621.3 " a kind of medicine for the treatment of diabetes " is exactly to utilize a strain microbial strains and other organic and inorganic chemicals to make BM oral liquid or the BM capsule medicine in order to the treatment diabetes for the metabolite extracting solution of culture medium fermentation.And for example: Beijing is great Chinese medicine preparation that " the novel diabetes preparation " that reach the development of scientific and technological development company be utilizes the metabolite of microbial solid fermentation to develop for main material is not the pure biological preparation of microbial metabolic products.The present invention extracts through the metabolite of the micropopulation of for many years experiment and research and utilization multiple beneficial and mixed culture fermentation thereof and has made hypoglycemic biopreparation and be used for treating diabetes.
Summary of the invention
The object of the invention is that the hypoglycemic biopreparation of developing is made up of multiple micropopulation and metabolite thereof, makes through methods such as the activation of routine, amplification culture, fermentation, filtration, slagging-off, degerming, lyophilizations.The comprehensive and systematic adjustment organism metabolism function of said preparation energy, the islet tissue of repairing pathological changes recovers its physiological function, promotes insulin secretion, increases insulin quantity and strengthens the sensitivity of β cell to insulin, suppress effectively and eliminate paathogenic factor, and then blood glucose, glucose in urine are reduced.Said preparation is checked and colibacillary testing identity through the animal toxicology of relevant health and epidemic prevention department: said preparation has no side effect, and escherichia coli all meet national standard.And take through the ordered series of numbers diabetics, its result proves that said preparation not only has obvious effects to blood sugar lowering, glucose in urine, and blood fat reducing and blood viscosity are also had certain curative effect.
Hypoglycemic biopreparation of the present invention, it is made up of multiple micropopulation and metabolite thereof, makes through methods such as the activation of routine, amplification culture, fermentation, filtration, slagging-off, degerming, lyophilizations; Multiple micropopulation in the said preparation is a saccharomycetic mixture commonly used on actinomycetes that can produce antibiotics in the antibacterial and Gram pharmaceutically commonly used lactobacillus that positive and negative are arranged and the fungus Chinese medicine; Metabolite is the metabolite that produces after the culture medium that micropopulation consumes.
The preparation method of hypoglycemic biopreparation is pressed routine step and is carried out:
A, at first mixed bacteria is activated, amplification culture, fermentation, fermentation process is the liquid submerged fermentation method, used culture medium is carbon source, nitrogenous source and inorganic salt in the fermentation, wherein carbon source is wheat bran or the Semen Maydis powder or the rice dregs of rice; Nitrogenous source is bean cake or soybean cake or the Semen arachidis hypogaeae dregs or the Semen Viciae fabae dregs of rice; Inorganic salt is sodium chloride or dipotassium hydrogen phosphate, carbon/nitrogen=10-30; The prescription of fermentation medium is the radix weight in grams for producing preparation with 250 liters of fermentation tanks: carbon source is the 2000-5000 gram, and nitrogenous source is the 100-300 gram, and inorganic salt is the 5-100 gram; Fermentation temperature 18-40 ℃, space changing 3-5 time, the fermentation pH value is 3.5-7.5, and the fermentation ventilation is volume ratio 1: 1, and the fermentation tank pressure is 0.01-0.08Mpa, and space changing 3 times, fermentation time are 25-90 hour;
B, fermentation liquid is promptly got biological blood sugar lowering revealing after the filtration of high speed centrifugation membrance separation, slagging-off, degerming, is that finished product gets final product through test package;
C, fermentation liquid is carried out lyophilization making powder after the high speed centrifugation membrance separation filters, again powder is made capsule or tablet with traditional method, is that finished product gets final product through test package.
Fermentation temperature space changing amplitude is 18-28 ℃ in the preparation method of hypoglycemic biopreparation, 28-33 ℃, and 33-40 ℃; Fermentation tank pressure conversion amplitude is 0.01-0.02Mpa, 0.02-0.04Mpa, 0.04-0.08Mpa.
Description of drawings
Fig. 1 is a process chart of the present invention
The specific embodiment
Embodiment 1 produces preparation with 250 liters of fermentation tanks
At first mixed bacteria is activated, amplification culture, fermentation, fermentation process is the liquid submerged fermentation method, used culture medium in the fermentation: carbon source wheat bran 2000 grams, nitrogenous source bean cake 100 grams, inorganic salt sodium chloride 5 grams, fermentation pH value 3.5, fermentation temperature 18-40 ℃, space changing 3 times, temperature is 18 ℃ for the first time, temperature is 28 ℃ for the second time, temperature is 38 ℃ for the third time, and the fermentation ventilation is volume ratio 1: 1, and the fermentation tank pressure is 0.01-0.08Mpa, fermentation time is 85 hours, and the total bacterium of product is measured 8,000,000,000/ml;
Fermentation liquid promptly being got biological blood sugar lowering again and reveal after the filtration of high speed centrifugation membrance separation, slagging-off, degerming, is that finished product gets final product through test package.
Embodiment 2 produces preparation with 250 liters of fermentation tanks
At first mixed bacteria is activated, amplification culture, fermentation, fermentation process is the liquid submerged fermentation method, used culture medium in the fermentation: carbon source Semen Maydis powder 3000 grams, nitrogenous source soybean cake 200 grams, inorganic salt dipotassium hydrogen phosphate 50 grams, fermentation pH value 5.5, fermentation temperature 18-40 ℃, space changing 5 times, temperature is 18 ℃ for the first time, and temperature is 23 ℃ for the second time, and temperature is 28 ℃ for the third time, 33 ℃ of the 4th temperature, 40 ℃ of the 5th temperature, the fermentation ventilation is volume ratio 1: 1, the fermentation tank pressure is 0.01-0.08Mpa, space changing 3 times, for the first time tank pressure 0.02Mpa, tank pressure 0.04Mpa, tank pressure 0.08Mpa for the third time for the second time, fermentation time is 30 hours, and the total bacterium of product is measured 9,000,000,000/ml;
Fermentation liquid being carried out lyophilization make powder after the high speed centrifugation membrance separation filters, again powder is made capsule or tablet with traditional method, is that finished product gets final product through test package.
Embodiment 3 produces preparation with 250 liters of fermentation tanks
At first mixed bacteria is activated, amplification culture, fermentation, fermentation process is the liquid submerged fermentation method, used culture medium in the fermentation: the carbon source rice dregs of rice 4000 grams, nitrogenous source Semen arachidis hypogaeae dregs 300 grams, fermentation pH value 7.5, fermentation temperature 18-40 ℃, space changing 3 times, temperature is 24 ℃ for the first time, temperature is 35 ℃ for the second time, temperature is 40 ℃ for the third time, and the fermentation ventilation is volume ratio 1: 1, and the fermentation tank pressure is 0.01-0.08Mpa, fermentation time is 25 hours, and the total bacterium of product is measured 7,000,000,000/ml;
Fermentation liquid promptly being got biological blood sugar lowering again and reveal after the filtration of high speed centrifugation membrance separation, slagging-off, degerming, is that finished product gets final product through test package;
Embodiment 4 produces preparation with 250 liters of fermentation tanks
At first mixed bacteria is activated, amplification culture, fermentation, fermentation process is the liquid submerged fermentation method, used culture medium in the fermentation: carbon source wheat bran 5000 grams, the nitrogenous source Semen Viciae fabae dregs of rice 300 grams, inorganic salt sodium chloride 100 grams, fermentation pH value 7.0, fermentation temperature 18-40 ℃, space changing 3 times, temperature is 20 ℃ for the first time, temperature is 30 ℃ for the second time, temperature is 38 ℃ for the third time, and the fermentation ventilation is volume ratio 1: 1, and the fermentation tank pressure is 0.01-0.08Mpa, space changing 3 times, for the first time tank pressure 0.01Mpa, tank pressure 0.02Mpa, tank pressure 0.04Mpa for the third time for the second time, fermentation time is 85 hours, and the total bacterium of product is measured 9,500,000,000/ml;
Again fermentation liquid being carried out lyophilization after the high speed centrifugation membrance separation filters and make powder, again powder is made capsule or tablet with traditional method, is that finished product gets final product through test package.

Claims (3)

1, a kind of hypoglycemic biopreparation is characterized in that it is made up of multiple micropopulation and metabolite thereof, makes through methods such as the activation of routine, amplification culture, fermentation, filtration, slagging-off, degerming, lyophilizations; Multiple micropopulation in the said preparation is a saccharomycetic mixture commonly used on actinomycetes that can produce antibiotics in the antibacterial and Gram pharmaceutically commonly used lactobacillus that positive and negative are arranged and the fungus Chinese medicine; Metabolite is the metabolite that produces after the culture medium that micropopulation consumes.
2, the preparation method of hypoglycemic biopreparation according to claim 1 is characterized in that pressing routine step and carries out:
A, at first mixed bacteria is activated, amplification culture, fermentation, fermentation process is the liquid submerged fermentation method, used culture medium is carbon source, nitrogenous source and inorganic salt in the fermentation, wherein carbon source is wheat bran or the Semen Maydis powder or the rice dregs of rice; Nitrogenous source is bean cake or soybean cake or the Semen arachidis hypogaeae dregs or the Semen Viciae fabae dregs of rice; Inorganic salt is sodium chloride or dipotassium hydrogen phosphate, carbon/nitrogen=10-30; The prescription of fermentation medium is a radix for restraining with 250 liters of fermentation tank production weight of formulation: carbon source is the 2000-5000 gram, and nitrogenous source is the 100-300 gram, and inorganic salt is the 5-100 gram; Fermentation temperature 18-40 ℃, space changing 3-5 time, the fermentation pH value is 3.5-7.5, and the fermentation ventilation is volume ratio 1: 1, and the fermentation tank pressure is 0.01-0.08Mpa, and space changing 3 times, fermentation time are 25-90 hour;
B, fermentation liquid is promptly got biological blood sugar lowering revealing after the filtration of high speed centrifugation membrance separation, slagging-off, degerming, is that finished product gets final product through test package;
C, fermentation liquid is carried out lyophilization making powder after the high speed centrifugation membrance separation filters, again powder is made capsule or tablet with traditional method, is that finished product gets final product through test package.
3, the preparation method of hypoglycemic biopreparation according to claim 2 is characterized in that fermentation temperature space changing amplitude is 18-28 ℃, 28-33 ℃, and 33-40 ℃; Fermentation tank pressure conversion amplitude is 0.01-0.02Mpa, 0.02-0.04Mpa, 0.04-0.08Mpa.
CNB011304502A 2001-11-16 2001-11-16 Hypoglycemic biopreparation Expired - Fee Related CN1239166C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CNB011304502A CN1239166C (en) 2001-11-16 2001-11-16 Hypoglycemic biopreparation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CNB011304502A CN1239166C (en) 2001-11-16 2001-11-16 Hypoglycemic biopreparation

Publications (2)

Publication Number Publication Date
CN1357360A true CN1357360A (en) 2002-07-10
CN1239166C CN1239166C (en) 2006-02-01

Family

ID=4669908

Family Applications (1)

Application Number Title Priority Date Filing Date
CNB011304502A Expired - Fee Related CN1239166C (en) 2001-11-16 2001-11-16 Hypoglycemic biopreparation

Country Status (1)

Country Link
CN (1) CN1239166C (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011063597A1 (en) * 2009-11-25 2011-06-03 Wang Liping Complex microbial preparation for treating diabetes and preparative method and use thereof
US8658156B2 (en) 2007-07-05 2014-02-25 Nestec S.A. Supplemention of maternal diet
CN103783407A (en) * 2014-01-08 2014-05-14 浙江工业大学 Method for processing low-energy extruded meal replacement powder

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8658156B2 (en) 2007-07-05 2014-02-25 Nestec S.A. Supplemention of maternal diet
US9308228B2 (en) 2007-07-05 2016-04-12 Nestec S.A. Supplemention of maternal diet
US9636369B2 (en) 2007-07-05 2017-05-02 Nestec S.A. Supplemention of maternal diet
WO2011063597A1 (en) * 2009-11-25 2011-06-03 Wang Liping Complex microbial preparation for treating diabetes and preparative method and use thereof
CN101703528B (en) * 2009-11-25 2012-07-04 王立平 Compound microbial preparation for treating diabetes, preparation method thereof and application thereof
CN103783407A (en) * 2014-01-08 2014-05-14 浙江工业大学 Method for processing low-energy extruded meal replacement powder
CN103783407B (en) * 2014-01-08 2015-10-28 浙江工业大学 A kind of processing method of low-yield extruding generation meal powder

Also Published As

Publication number Publication date
CN1239166C (en) 2006-02-01

Similar Documents

Publication Publication Date Title
EP2386624B1 (en) Complex microbial preparation for treating diabetes and preparative method and use thereof
CN107156587A (en) Active probiotic solid beverage and its treatment diabetes B in apply
CN104082740B (en) A kind of have intervention or the composition improving diabetes and preparation method thereof
CN110150669A (en) A kind of probiotic composition and its application suitable for patients with diabetes mellitus
CN105614774A (en) Preparation method of fruit and vegetable active ferment liquid
CN102845695B (en) Konjac fermented food and beverage and preparation method thereof
CN106578918A (en) Selenium-enriched suaeda salsa nutritional health-care fine dried noodles and production technology thereof
CN105661515A (en) Enzyme lozenges for three-hypers and preparation method thereof
CN107343889A (en) A kind of peacilomyce hepiahi bacterium fermentation culture medium for being used to treat the 1st type or diabetes B
CN108523112B (en) Silkworm chrysalis food base material and preparation method and application thereof
CN1239166C (en) Hypoglycemic biopreparation
CN103263484B (en) A kind of fermentation process of bran of Radix Et Rhizoma Fagopyri Tatarici and tunning thereof
CN111228316A (en) Composite probiotics for improving diabetes
CN103549008B (en) Liquid dairy product rich in cellulose
CN102805341B (en) Five-time fermentation preparation method of Chinese yam, radix astragali and salviae miltiorrhizae capsule
CN1272025C (en) Solid fermented fungus powder as food and medicine
CN1148962A (en) Prescription of oral liquid for regulating blood sugar and blood lipid and preparation thereof
CN114181975B (en) Multi-strain composite fermentation method for fresh and tender corn silk
CN112870235B (en) Application of hericium erinaceus powder in preparation of product for preventing or treating hyperuricemia-related diseases
CN1274339C (en) Anqi preparation
CN1442151A (en) Mackefulan immune liquid
CN113952420A (en) Preparation method of blood sugar reducing essence by utilizing bifidobacterium lactis fermented composite traditional Chinese medicine extract
CN1468607A (en) Recipe of diabetes treating medicine
CN105641687A (en) Compound blood glucose reducing medicine composition and preparing method thereof
CN1247224C (en) Application of opium seed in medicine for preparing diabetes

Legal Events

Date Code Title Description
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C06 Publication
PB01 Publication
C14 Grant of patent or utility model
GR01 Patent grant
C19 Lapse of patent right due to non-payment of the annual fee
CF01 Termination of patent right due to non-payment of annual fee